1. EZH2 inhibition: a promising strategy to prevent cancer immune editing
   Ning Kang et al, 2020, Epigenomics CrossRef
2. STAT3 and p53: Dual Target for Cancer Therapy
   Thu-Huyen Pham et al, 2020, Biomedicines CrossRef
3. Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF‐1α‐dependent signaling pathway
   Yingfeng Shi et al, 2022, The Journal of Pathology CrossRef
4. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
   Anthos Christofides et al, 2016, Oncotarget CrossRef
5. Live cell dynamics of the NF-Y transcription factor
   David G. Priest et al, 2021, Scientific Reports CrossRef
6. The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis
   Peng Gao et al, 2017, Oncotarget CrossRef
7. Loss of Trem2 in microglia leads to widespread disruption of cell coexpression networks in mouse brain
   Guillermo Carbajosa et al, 2018, Neurobiology of Aging CrossRef
8. Expression and function of NF-Y subunits in cancer
   Diletta Dolfini et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
9. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells
   Min Zheng et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
10. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma
    Bin Huang et al, 2018, Pathology - Research and Practice CrossRef
11. Symphony of epigenetic and metabolic regulation—interaction between the histone methyltransferase EZH2 and metabolism of tumor
    Tengrui Zhang et al, 2020, Clinical Epigenetics CrossRef
12. YAP via interacting with STAT3 regulates VEGF-induced angiogenesis in human retinal microvascular endothelial cells
    Manhui Zhu et al, 2018, Experimental Cell Research CrossRef
13. NF‐YA promotes the cell proliferation and tumorigenic properties by transcriptional activation of SOX2 in cervical cancer
    Wen‐Ting Yang et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
14. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis
    Minghui Zhao et al, 2019, International Journal of Oncology CrossRef
15. LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis
    Xin Pan et al, 2018, Cell Death & Disease CrossRef
16. The phosphorylatable Ser320 of NF‐YA is involved in DNA binding of the NF‐Y trimer
    Andrea Bernardini et al, 2019, The FASEB Journal CrossRef
17. Activation of the STAT3/microRNA‐21 pathway participates in angiotensin II‐induced angiogenesis
    Li‐Yuan Chen et al, 2019, Journal of Cellular Physiology CrossRef
18. EZH2 can be used as a therapeutic agent for inhibiting endothelial dysfunction
    Li Sun et al, 2023, Biochemical Pharmacology CrossRef